Upstate Active Clinical Trials

Study Title:

A Study to Assess the Utility of MDM2/CDK4 Immunohistochemistry of a Tru-Cut Biopsy to
Differentiate Between Benign Lipomas and Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma
(“ALT/WDLS”)

What is the purpose of the study?

This research study is being conducted to determine if performing a pre-operative core biopsy of the tumor and testing the biopsy material using immunohistochemical analyses can distinguish an atypical lipomatous tumor (ALT/WDLS) from a benign lipoma.

Upstate Institutional Review Board (IRB) Number:

1203583

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Timothy A Damron

Who can I contact for more information?

Name: Tina M Craig
Phone: 315-464-8618
Email: craigt@upstate.edu

Return to Previous Page || Search Again

Top